The French National Alliance for Life Sciences and Health

AVIESAN

Prof. André SyrotaChairman and CEO of InsermPresident of Aviesan

STOA, Brussels, June 2012

1

The scientific and political context

- Changes in the French research and higher education landscape. 2007: The autonomy of the universities. 2009: University Hospitals become research operators

. 2011: “Investments for the future” : 35 billion € (2.5 billion € for life and health sciences – equipments, cohorts, infrastructures, university hospital institutes, technological research institutes,…)

- The scientific challenges of the 21st century. Biology becoming « an integrative science » . New Health challenges: personalised medicine, ageing, emerging and reemerging diseases, health care systems,…

- A complex organisation in Health and Life sciences

The French National Alliance for Life and Health Sciences (Aviesan)

3

4

Aviesan main objectives

• Scientific coordination • Strategic analysis • Scientific foresight• Programming (National and European levels)

• Operational coordination • Partnership with universities (funding, human resources)• Transfer of knowledge• Simplification

More visibility and reactivityTo share priorities on structuring projects

5

Aviesan10 multi-organization thematic institutes (Itmos)

Molecular and structural

bases of living organisms

Cell biology, development and evolution

Genetics, genomics and

bioinformatics

Immunology, hematology,

and pneumology

Microbiology and infectious

diseases

ANRS

Public health Health

Technologies

Cancer

INCa

Circulation,metabolism, and nutrition

6

Aviesan: Achievements

• Strategic analysis & scientific foresight

• Scientific animationAnnual conferences, thematic workshops and working groups (H1N1, Nutrition and Cancer, Vaccines, Radiobiology, Environment and Cancer, Epigenetics, Bioinformatics, rare diseases, etc)

• ProgrammingNational Research Agency (ANR), Thematic agencies within Aviesan Itmos, Investments for the future: research infrastructuresEuropean level: JPI, ESFRI BMS, FP7 Health priority, H 2020

• Structuring actionsH1N1, Research infrastructures, Environment and Health, Synthetic

Biology

• Partnership with Universities

• Transfer of knowledge

7

Aviesan: Transfer of Knowledge

- Annual meeting at the Governmental levelNeurosciences, Metabolism and Cardiovascular, Infectious diseasesR&D dating

- Sanofi Aventis-Aviesan agreementSponsorshipCollaboration agreementsJoint funding for project maturation

- Covalliance

- The epidemiologic portal

Strategic Council for health industry: Aviesan as the most appropriate partner

Thank you for your attention

8